The outlook of companies tied to Viagra's history presents a complex investment scenario . While the initial success generated substantial returns , generic copies have significantly impacted sales . Investing in associated pharmaceutical firms now requires a discerning assessment of patent protection , evolving patient trends , and the prospect fo